1.Renwick, AG, Flynn, A, Fletcher, RJ et al. (2004) Risk–benefit analysis of micronutrients. Food Chem Toxicol 42, 1903–1922.
2.European Food Safety Authority (2007) Summary Report EFSA Scientific Colloquium 6. Risk-benefit analysis of foods. Tabiano, Italy: EFSA.
3.Mertz, W (1995) Risk assessment of essential trace elements: new approaches to setting recommended dietary allowances and safety limits. Nutr Rev 53, 179–185.
4.EFSA (2006) Tolerable Upper Intake Levels for Vitamins and Minerals. Scientific Committee on Food, Scientific Panel on Dietetic Products, Nutrition and Allergies. Tabiano, Italy: European Food Safety Authority. ISBN 92-9199-014-0.
5.Schümann, K (2006) Dietary reference intakes for trace elements revisited. J Trace Elem Med Biol 20, 59–61.
6.Olin, SS (1998) Between a rock and a hard place: methods for setting dietary allowances and exposure limits for essential minerals. J Nutr 128, 364S–367S.
7.Renwick, AG (2006) Toxicology of micronutrients: adverse effects and uncertainty. J Nutr 136, 493S–501S.
8.de Graaf, AA, Freidig, AP, De Roos, B et al. (2009) Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput Biol 5, e1000554 (Epublication ahead of print 26 November 2009).
9.Meltzer, HM, Aro, A, Andersen, NL et al. (2003) Risk analysis applied to food fortification. Public Health Nutr 6, 281–290.
10.Collins, JF, Prohaska, JR & Knutson, MD (2010) Metabolic crossroads of iron and copper. Nutr Rev 68, 133–147.
11.Hurrell, R & Egli, I (2010) Iron bioavailability and dietary reference values. Am J Clin Nutr 91, 1461S–1467S.
12.Harvey, LJ, Ashton, K, Hooper, L et al. (2009) Methods of assessment of copper status in humans: a systematic review. Am J Clin Nutr 89, 2009S–2024S.
13.Zeleniuch-Jacquotte, A, Zhang, Q, Dai, J et al. (2007) Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol 17, 354–358.
14.Hallberg, L (1981) Bioavailable nutrient density: a new concept applied in the interpretation of food iron absorption data. Am J Clin Nutr 34, 2242–2247.
15.Institute of Medicine (2010). Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease [Micheel, CM and Ball, JR]. Washington DC: National Academies Press.
16.Goldhaber, SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38, 232–242.
17.Renwick, AG & Walker, R (2008) Risk assessment of micronutrients. Toxicol Lett 180, 123–130.
18.Renwick, AG, Dragsted, LO, Fletcher, RJ et al. (2008) Minimising the population risk of micronutrient deficiency and over-consumption: a new approach using selenium as an example. Eur J Nutr 47, 17–25.
19.Food and Nutrition Board, Institute of Medicine (2001) Dietary Reference Intakes. A Report of the Panel on Micronutrients. Washington, DC: National Academies Press.
20.Nordic Nutrition Council (2004). Nordic Nutrition Recommendations 2004: Integrating Nutrition and Physical Activity. 4th ed. Copenhagen, Denmark: Nordic Council of Ministers.
21.Reports of the Scientific Committee for Food (1993) Nutrient and Energy Intakes for the European Community. Luxembourg: Commission of the European Communities.
22.Doets, EL, de Wit, LS, Dhonukshe-Rutten, RA et al. (2008) Current micronutrient recommendations in Europe: towards understanding their differences and similarities. Eur J Nutr 47, 17–40.
23.O'Donohue, JW, Reid, MA, Varghese, A et al. (1993) Micronodular cirrhosis and acute liver failure due to chronic copper self-intoxication. Eur J Gastroenterol 5, 561–562.
24.O'Donohue, J, Reid, M, Varghese, A et al. (1999) A case of adult chronic copper self-intoxication resulting in cirrhosis. Eur J Med Res 4, 252.
25.Danzeisen, R, Araya, M, Harrison, B et al. (2007) How reliable and robust are current biomarkers for copper status? Br J Nutr 98, 676–683.
26.Goodman, BP, Bosch, EP, Ross, MA et al. (2009) Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol Neurosurg Psychiatry 80, 524–527.
27.Stern, BR, Solioz, M, Krewski, D et al. (2007) Copper and human health: biochemistry, genetics, and strategies for modelling dose-response relationships. J Toxicol Environ Health, Part B 10, 157–222.
28.Gambling, L & McArdle, HJ (2004) Iron, copper and fetal development. Proc Nutr Soc 63, 553–562.
29.Harvey, LJ & McArdle, HJ (2008) Biomarkers of copper status: as brief update. Br J Nutr 99, suppl. 3, S10–S13.
30.Olivares, M, Méndez, MA, Astudillo, PA et al. (2008) Present situation of biomarkers for copper status. Am J Clin Nutr 88, 859S–862S.
31.Krewski, D, Chambers, A & Birkett, N (2010) The use of categorical regression in modelling copper exposure–response relationships. J Toxicol Environ Health, Part A 73, 187–207.
32.Krewski, D, Chambers, A, Stern, BR et al. (2010) Development of a copper database for exposure-response analysis. J Toxicol Environ Health, Part A 73, 208–216.
33.Dourson, ML, Teuschler, LK, Durkin, PR et al. (1997) Categorical regression of toxicity data: a case study using aldicarb. Regul Toxicol Pharmacol 25, 121–129.
34.Haber, L, Strickland, JA & Guth, DJ (2001) Categorical regression analysis of toxicity data. Comments toxicol 7, 437–452.
35.Harris, ED (2000) Cellular copper transport and metabolism. Annu Rev Nutr 20, 291–310.
36.Mercer, JF (2001) The molecular basis of copper transport diseases. Trends Mol Med 7, 64–69.
37.Llanos, RM & Mercer, JF (2002) The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol 21, 259–270.
38.Kaler, SG (1998) Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am J Clin Nutr 67, 1029S–1034S.
39.Kaler, SG (1996) Menkes disease mutations and response to early copper histidine treatment. Nat Genet 13, 21–22.
40.Ala, A, Walker, AP, Ashkan, K et al. (2007) Wilson's disease. Lancet 369, 397–408.
41.Scheinberg, IH & Sternlieb, I (1996) Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr 63, 842S–845S.
42.Roberts, EA & Schilsky, ML (2003) A practice guideline on Wilson disease. Hepatology 37, 1475–1492.
43.Das, SK & Ray, K (2006) Wilson's disease: an update. Nat Clin Pract Neurol 2, 482–493.
44.National Research Council (2000) Copper in Drinking Water [Committee on Copper in Drinking Water, editor]. Washington DC: National Academy Press.
45.Brewer, GJ (2000) Editorial. J Trace Elem Exp Med 13, 249–254.
46.Müller, T, Müller, W & Feichtinger, H (1998) Idiopathic copper toxicosis. Am J Clin Nutr 67, 1082S–1086S.
47.Müller, T, Feichtinger, H & Berger, H (1996) Endemic tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 347, 877–880.
48.Tanner, MS (1998) Role of copper in Indian childhood cirrhosis. Am J Clin Nutr 67, 1074S–1081S.
49.Scientific Advisory Committee on Nutrition. (2010) Iron and Health. London: The Stationery Office (In the Press).
50.Blanck, HM, Cogswell, ME, Gillespie, C et al. (2005) Iron supplement use and iron status among US adults: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 82, 1024–1031.
51.Harvey, LJ, Armah, CN, Dainty, JR et al. (2005) Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br J Nutr 94, 557–564.
52.Roe, MA, Collings, R, Dainty, JR et al. (2009) Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr 89, 1088–1091.
53. Report on Health and Social Subjects 41: Dietary Reference Values (DRVs) for Food Energy and Nutrients for the UK, Report of the Panel on DRVs of the Committee on Medical Aspects of Food Policy (COMA) 1991. London: The Stationary Office.
54.Zimmermann, MB, Zeder, C, Muthayya, S et al. (2008) Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes (Lond) 32, 1098–1104.
55.del Giudice, EM, Santoro, N, Amato, A et al. (2009) Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 94, 5102–5107.
56.Aeberli, I, Hurrell, RF & Zimmermann, MB (2009) Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes (Lond) 33, 1111–1117.
57.Institute of Medicine (2006) Iron. In Dietary Reference Intakes. The Essential Guide to Nutrient Requirements, pp. 329–339 [Otten, JJ Pitzi Hellwig, J and Meyers, LD, editors]. Washington, DC: The National Academies Press.
58.World Health Organisation and Food and Agriculture Organisation of the United Nations (2004) Vitamin and Mineral Requirements in Human Nutrition. Geneva: World Health Organization.
59.Cook, JD, Flowers, CH & Skikne, BS (2003) The quantitative assessment of body iron. Blood 101, 3359–3364.
60.Barrett, JF, Whittaker, PG, Williams, JG et al. (1994) Absorption of non-haem iron from food during normal pregnancy. BMJ 309, 79–82.
61.Gibson, RS (2005) Principles of Nutritional Assessment, 2nd edn. Oxford: Oxford University Press.
62.Weiss, G & Goodnough, LT (2005) Anemia of chronic disease. N Engl J Med 352, 1011–1023.
63.Expert Group on Vitamins and Minerals (2003) Safe Upper Levels for Vitamins and Minerals. London: Food Standards Agency.
64.Varea, C, Bernis, C, Montero, P et al. (2000) Secular trend and intrapopulational variation in age at menopause in Spanish women. J Biosoc Sci 32, 383–393.
65.Rybo, G & Hallberg, L (1966) Influence of heredity and environment on normal menstrual blood loss. A study of twins. Acta Obstet Gynecol Scand 45, 389–410.
66.Janssen, MCH & Swinkels, DW (2009) Hereditary haemochromatosis. Best Prac Res Clin Gastro 23, 179–183.
67.Wrede, CE, Hutzler, S, Bollheimer, LC et al. (2004) Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Isr Med Assoc J 6, 30–33.
68.Burke, W, Imperatore, G, McDonnell, SM et al. (2000) Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Genet Med 2, 271–277.
69.Roe, MA, Heath, AL, Oyston, SL et al. (2005) Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 81, 814–821.